Literature DB >> 30393877

MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.

Renata Santos Almeida1, Matheus Costa E Silva2, Luiz Lehmann Coutinho3, Renan Garcia Gomes1, Francisco Pedrosa4, Juliana Doblas Massaro2, Eduardo Antônio Donadi2, Norma Lucena-Silva1,4.   

Abstract

MicroRNAs (miRNAs) play a critical role on biological and cellular processes; the search for functional markers may be of importance for differential diagnosis, prognosis, and development of new therapeutic regimens. In this context, we evaluated the bone marrow miRNA profile of Brazilian children exhibiting T- or B-cell acute lymphoblastic leukemia (T-ALL or B-ALL), using massive parallel sequencing, using the HiSeq 2500 platform (Illumina). The differential expression analysis was conducted considering a leave-one-out approach and FDR ≤ 0.05. Machine learning algorithms were applied to search for the disease subset biomarkers. Target prediction, functional enrichment, and classification of biological categories were also performed. Sixteen miRNAs were differentially expressed between T- and B-ALL, of which 10 (miR-708-5p, miR-497-5p, miR-151a-5p, miR-151b, miR-371b-5p, miR-455-5p, miR-195-5p, miR-1266-5p, miR-574-5p, and miR-425-5p) were downregulated and six (miR-450b-5p, miR-450a-5p, miR-542-5p, miR-424-5p, miR-629-5p, and miR-29c-5p) were upregulated in childhood T-ALL. These miRNAs may be used for distinguishing childhood lymphoblastic leukemia subtypes, since it provided the clear separation of patients in these two distinct groups. Six relevant biological pathways were identified according to their role in leukemia, namely, viral carcinogenesis, cell cycle, and B-cell receptor signaling pathways for induced miRNAs and TGF-beta signaling, apoptosis, and NF-kappa B signaling for the repressed miRNAs, of which several miRNA gene targets participate in cell differentiation and hematopoiesis processes. Machine learning analysis pointed out miR-29c-5p expression as the best discriminator between childhood T- and B-ALL, which is involved in calcium signaling, critical for B-cell lymphocyte fate. Further studies are needed to assure the role of the 16 miRNAs and miR-29c-5p on acute lymphoblastic leukemia subtypes and on disease prognosis.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  B-ALL; T-ALL; acute lymphoblastic leukemia; biomarker; miRNome sequencing; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30393877     DOI: 10.1002/hon.2567

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  17 in total

1.  Differential mRNA and long noncoding RNA expression profiles in pediatric B-cell acute lymphoblastic leukemia patients.

Authors:  Jing Xia; Mengjie Wang; Yi Zhu; Chaozhi Bu; Tianyu Li
Journal:  BMC Pediatr       Date:  2022-01-03       Impact factor: 2.125

Review 2.  Putting the "mi" in omics: discovering miRNA biomarkers for pediatric precision care.

Authors:  Chengyin Li; Rhea E Sullivan; Dongxiao Zhu; Steven D Hicks
Journal:  Pediatr Res       Date:  2022-07-29       Impact factor: 3.953

3.  Differentially Expressed Bone Marrow microRNAs Are Associated With Soluble HLA-G Bone Marrow Levels in Childhood Leukemia.

Authors:  Renata Santos Almeida; Thailany Thays Gomes; Felipe Souza Araújo; Sávio Augusto Vieira de Oliveira; Jair Figueredo Santos; Eduardo Antônio Donadi; Norma Lucena-Silva
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

4.  Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Małgorzata Dawidowska; Roman Jaksik; Monika Drobna; Bronisława Szarzyńska-Zawadzka; Maria Kosmalska; Łukasz Sędek; Ludomiła Machowska; Anna Lalik; Monika Lejman; Marek Ussowicz; Krzysztof Kałwak; Jerzy R Kowalczyk; Tomasz Szczepański; Michał Witt
Journal:  Neoplasia       Date:  2019-02-11       Impact factor: 5.715

5.  Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine.

Authors:  Li-Juan Tang; Guo-Kang Sun; Ting-Juan Zhang; De-Hong Wu; Jing-Dong Zhou; Bei-Bei Ma; Zi-Jun Xu; Xiang-Mei Wen; Qin Chen; Dong-Ming Yao; Jun Qian; Ji-Chun Ma; Jiang Lin
Journal:  Cancer Cell Int       Date:  2019-07-10       Impact factor: 5.722

6.  Differentially expressed circulating miRNAs in postmenopausal osteoporosis: a meta-analysis.

Authors:  Elif Pala; Tuba Denkçeken
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

Review 7.  Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia.

Authors:  Narges Aberuyi; Soheila Rahgozar; Elaheh Sadat Ghodousi; Kamran Ghaedi
Journal:  Front Oncol       Date:  2020-01-17       Impact factor: 6.244

Review 8.  Non-Coding RNA Signatures of B-Cell Acute Lymphoblastic Leukemia.

Authors:  Princess D Rodriguez; Hana Paculova; Sophie Kogut; Jessica Heath; Hilde Schjerven; Seth Frietze
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

9.  Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia.

Authors:  Sai Huang; Zhi Huang; Chao Ma; Lan Luo; Yan-Fen Li; Yong-Li Wu; Yuan Ren; Cong Feng
Journal:  Ann Transl Med       Date:  2020-03

10.  The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro.

Authors:  Ulrike Erb; Julia Hikel; Svenja Meyer; Hiroshi Ishikawa; Thomas S Worst; Katja Nitschke; Philipp Nuhn; Stefan Porubsky; Christel Weiss; Horst Schroten; Rüdiger Adam; Michael Karremann
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.